Cargando…

Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery

IMPORTANCE: Cytoreductive surgery (CRS) is one of the most complex operations in surgical oncology with significant morbidity, and improved risk prediction tools are critically needed. Machine learning models can potentially overcome the limitations of traditional multiple logistic regression (MLR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Huiyu, Eftekhari, Zahra, Carlin, Cameron, Veerapong, Jula, Fournier, Keith F., Johnston, Fabian M., Dineen, Sean P., Powers, Benjamin D., Hendrix, Ryan, Lambert, Laura A., Abbott, Daniel E., Vande Walle, Kara, Grotz, Travis E., Patel, Sameer H., Clarke, Callisia N., Staley, Charles A., Abdel-Misih, Sherif, Cloyd, Jordan M., Lee, Byrne, Fong, Yuman, Raoof, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/
https://www.ncbi.nlm.nih.gov/pubmed/35612856
http://dx.doi.org/10.1001/jamanetworkopen.2022.12930
_version_ 1784713688812355584
author Deng, Huiyu
Eftekhari, Zahra
Carlin, Cameron
Veerapong, Jula
Fournier, Keith F.
Johnston, Fabian M.
Dineen, Sean P.
Powers, Benjamin D.
Hendrix, Ryan
Lambert, Laura A.
Abbott, Daniel E.
Vande Walle, Kara
Grotz, Travis E.
Patel, Sameer H.
Clarke, Callisia N.
Staley, Charles A.
Abdel-Misih, Sherif
Cloyd, Jordan M.
Lee, Byrne
Fong, Yuman
Raoof, Mustafa
author_facet Deng, Huiyu
Eftekhari, Zahra
Carlin, Cameron
Veerapong, Jula
Fournier, Keith F.
Johnston, Fabian M.
Dineen, Sean P.
Powers, Benjamin D.
Hendrix, Ryan
Lambert, Laura A.
Abbott, Daniel E.
Vande Walle, Kara
Grotz, Travis E.
Patel, Sameer H.
Clarke, Callisia N.
Staley, Charles A.
Abdel-Misih, Sherif
Cloyd, Jordan M.
Lee, Byrne
Fong, Yuman
Raoof, Mustafa
author_sort Deng, Huiyu
collection PubMed
description IMPORTANCE: Cytoreductive surgery (CRS) is one of the most complex operations in surgical oncology with significant morbidity, and improved risk prediction tools are critically needed. Machine learning models can potentially overcome the limitations of traditional multiple logistic regression (MLR) models and provide accurate risk estimates. OBJECTIVE: To develop and validate an explainable machine learning model for predicting major postoperative complications in patients undergoing CRS. DESIGN, SETTING, AND PARTICIPANTS: This prognostic study used patient data from tertiary care hospitals with expertise in CRS included in the US Hyperthermic Intraperitoneal Chemotherapy Collaborative Database between 1998 and 2018. Information from 147 variables was extracted to predict the risk of a major complication. An ensemble-based machine learning (gradient-boosting) model was optimized on 80% of the sample with subsequent validation on a 20% holdout data set. The machine learning model was compared with traditional MLR models. The artificial intelligence SHAP (Shapley additive explanations) method was used for interpretation of patient- and cohort-level risk estimates and interactions to define novel surgical risk phenotypes. Data were analyzed between November 2019 and August 2021. EXPOSURES: Cytoreductive surgery. MAIN OUTCOMES AND MEASURES: Area under the receiver operating characteristics (AUROC); area under the precision recall curve (AUPRC). RESULTS: Data from a total 2372 patients were included in model development (mean age, 55 years [range, 11-95 years]; 1366 [57.6%] women). The optimized machine learning model achieved high discrimination (AUROC: mean cross-validation, 0.75 [range, 0.73-0.81]; test, 0.74) and precision (AUPRC: mean cross-validation, 0.50 [range, 0.46-0.58]; test, 0.42). Compared with the optimized machine learning model, the published MLR model performed worse (test AUROC and AUPRC: 0.54 and 0.18, respectively). Higher volume of estimated blood loss, having pelvic peritonectomy, and longer operative time were the top 3 contributors to the high likelihood of major complications. SHAP dependence plots demonstrated insightful nonlinear interactive associations between predictors and major complications. For instance, high estimated blood loss (ie, above 500 mL) was only detrimental when operative time exceeded 9 hours. Unsupervised clustering of patients based on similarity of sources of risk allowed identification of 6 distinct surgical risk phenotypes. CONCLUSIONS AND RELEVANCE: In this prognostic study using data from patients undergoing CRS, an optimized machine learning model demonstrated a superior ability to predict individual- and cohort-level risk of major complications vs traditional methods. Using the SHAP method, 6 distinct surgical phenotypes were identified based on sources of risk of major complications.
format Online
Article
Text
id pubmed-9133947
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-91339472022-06-09 Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery Deng, Huiyu Eftekhari, Zahra Carlin, Cameron Veerapong, Jula Fournier, Keith F. Johnston, Fabian M. Dineen, Sean P. Powers, Benjamin D. Hendrix, Ryan Lambert, Laura A. Abbott, Daniel E. Vande Walle, Kara Grotz, Travis E. Patel, Sameer H. Clarke, Callisia N. Staley, Charles A. Abdel-Misih, Sherif Cloyd, Jordan M. Lee, Byrne Fong, Yuman Raoof, Mustafa JAMA Netw Open Original Investigation IMPORTANCE: Cytoreductive surgery (CRS) is one of the most complex operations in surgical oncology with significant morbidity, and improved risk prediction tools are critically needed. Machine learning models can potentially overcome the limitations of traditional multiple logistic regression (MLR) models and provide accurate risk estimates. OBJECTIVE: To develop and validate an explainable machine learning model for predicting major postoperative complications in patients undergoing CRS. DESIGN, SETTING, AND PARTICIPANTS: This prognostic study used patient data from tertiary care hospitals with expertise in CRS included in the US Hyperthermic Intraperitoneal Chemotherapy Collaborative Database between 1998 and 2018. Information from 147 variables was extracted to predict the risk of a major complication. An ensemble-based machine learning (gradient-boosting) model was optimized on 80% of the sample with subsequent validation on a 20% holdout data set. The machine learning model was compared with traditional MLR models. The artificial intelligence SHAP (Shapley additive explanations) method was used for interpretation of patient- and cohort-level risk estimates and interactions to define novel surgical risk phenotypes. Data were analyzed between November 2019 and August 2021. EXPOSURES: Cytoreductive surgery. MAIN OUTCOMES AND MEASURES: Area under the receiver operating characteristics (AUROC); area under the precision recall curve (AUPRC). RESULTS: Data from a total 2372 patients were included in model development (mean age, 55 years [range, 11-95 years]; 1366 [57.6%] women). The optimized machine learning model achieved high discrimination (AUROC: mean cross-validation, 0.75 [range, 0.73-0.81]; test, 0.74) and precision (AUPRC: mean cross-validation, 0.50 [range, 0.46-0.58]; test, 0.42). Compared with the optimized machine learning model, the published MLR model performed worse (test AUROC and AUPRC: 0.54 and 0.18, respectively). Higher volume of estimated blood loss, having pelvic peritonectomy, and longer operative time were the top 3 contributors to the high likelihood of major complications. SHAP dependence plots demonstrated insightful nonlinear interactive associations between predictors and major complications. For instance, high estimated blood loss (ie, above 500 mL) was only detrimental when operative time exceeded 9 hours. Unsupervised clustering of patients based on similarity of sources of risk allowed identification of 6 distinct surgical risk phenotypes. CONCLUSIONS AND RELEVANCE: In this prognostic study using data from patients undergoing CRS, an optimized machine learning model demonstrated a superior ability to predict individual- and cohort-level risk of major complications vs traditional methods. Using the SHAP method, 6 distinct surgical phenotypes were identified based on sources of risk of major complications. American Medical Association 2022-05-25 /pmc/articles/PMC9133947/ /pubmed/35612856 http://dx.doi.org/10.1001/jamanetworkopen.2022.12930 Text en Copyright 2022 Deng H et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Deng, Huiyu
Eftekhari, Zahra
Carlin, Cameron
Veerapong, Jula
Fournier, Keith F.
Johnston, Fabian M.
Dineen, Sean P.
Powers, Benjamin D.
Hendrix, Ryan
Lambert, Laura A.
Abbott, Daniel E.
Vande Walle, Kara
Grotz, Travis E.
Patel, Sameer H.
Clarke, Callisia N.
Staley, Charles A.
Abdel-Misih, Sherif
Cloyd, Jordan M.
Lee, Byrne
Fong, Yuman
Raoof, Mustafa
Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery
title Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery
title_full Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery
title_fullStr Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery
title_full_unstemmed Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery
title_short Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery
title_sort development and validation of an explainable machine learning model for major complications after cytoreductive surgery
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133947/
https://www.ncbi.nlm.nih.gov/pubmed/35612856
http://dx.doi.org/10.1001/jamanetworkopen.2022.12930
work_keys_str_mv AT denghuiyu developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT eftekharizahra developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT carlincameron developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT veerapongjula developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT fournierkeithf developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT johnstonfabianm developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT dineenseanp developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT powersbenjamind developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT hendrixryan developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT lambertlauraa developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT abbottdaniele developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT vandewallekara developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT grotztravise developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT patelsameerh developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT clarkecallisian developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT staleycharlesa developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT abdelmisihsherif developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT cloydjordanm developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT leebyrne developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT fongyuman developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery
AT raoofmustafa developmentandvalidationofanexplainablemachinelearningmodelformajorcomplicationsaftercytoreductivesurgery